The ROE as of December 2025 (TTM) for China Resources Pharmaceutical Group Limited (3320.HK) is 5.79%

According to China Resources Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current ROE is 5.79%. This represents a change of 68.25% compared to the average of 3.44% of the last 4 quarters.

China Resources Pharmaceutical Group Limited (3320.HK) Historical ROE (quarterly & annually)

How has 3320.HK ROE performed in the past?

The mean historical ROE of China Resources Pharmaceutical Group Limited over the last ten years is 8.05%. The current 5.79% ROE has changed -28.08% with respect to the historical average. Over the past ten years (40 quarters), 3320.HK's ROE was at its highest in in the December 2013 quarter at 15.27%. The ROE was at its lowest in in the January 2013 quarter at 0%.

China Resources Pharmaceutical Group Limited (3320.HK) ROE by Quarter and Year

Discovering the peaks and valleys of China Resources Pharmaceutical Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China Resources Pharmaceutical Group Limited (3320.HK) Average ROE

How has 3320.HK ROE performed in the past?

The current ROE of China Resources Pharmaceutical Group Limited (3320.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

China Resources Pharmaceutical Group Limited (3320.HK) ROE vs. Peers

How is 3320.HK’s ROE compared to its peers?

China Resources Pharmaceutical Group Limited’s ROE is less than Grand Pharmaceutical Group Limited (12.37%), less than Livzon Pharmaceutical Group Inc. (15.39%), less than China Medical System Holdings Limited (9.90%), less than The United Laboratories International Holdings Limited (20.45%), less than Xuanzhubio-b (0%), less than Asymchem Laboratories (Tianjin) Co., Ltd. (6.07%), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (8.00%), less than Simcere Pharmaceutical Group Limited (12.31%), less than HUTCHMED (China) Limited (46.95%), less than Shandong Weigao Group Medical Polymer Company Limited (8.22%),

Build a custom stock screener for China Resources Pharmaceutical Group Limited (3320.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Resources Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China Resources Pharmaceutical Group Limited (3320.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China Resources Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.